Hello, Fool! | Login | Signup | My Fool
Dec 2, 2008 12:24 AM ET | Feedback | Site Changes | Help
Choose a Broker | Fool's Two Top Stocks
Home
Sponsored By
By Associated Press June 12, 2008 | Comments (0)
Recs
Fiscal 2008 fourth-quarter results for biotechnology company Repligen Corp.
Net Loss: $3.2 million
Net Loss Per Share: 10 cents
Revenue: $3.3 million.
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.
Javascript is required to comment on Fool articles.
DocumentId: 663763, ~/articles/articlehandler.aspx, 12/2/2008 12:24:51 AM,
Signing up allows you to comment on articles and on the discussion boards.
Already registered? Login Here
We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement
Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.
CAPS Rating 5/5 Stars
$3.50
-0.40 (-10.26%)
Outperform282
Underperform8
All stories about RGEN
Terms & Conditions
RSS Headlines
Fool UK